Feilong Zhou

ORCID: 0009-0003-3347-8529
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Electrocatalysts for Energy Conversion
  • Advanced Drug Delivery Systems
  • Advancements in Transdermal Drug Delivery
  • Advanced battery technologies research
  • Pharmacological Effects of Natural Compounds
  • Catalytic Processes in Materials Science
  • Curcumin's Biomedical Applications
  • Supercapacitor Materials and Fabrication
  • Ubiquitin and proteasome pathways
  • Cytokine Signaling Pathways and Interactions
  • RNA Interference and Gene Delivery
  • Surfactants and Colloidal Systems
  • Fuel Cells and Related Materials
  • Nanoparticle-Based Drug Delivery
  • Nanocomposite Films for Food Packaging
  • Nanoporous metals and alloys
  • Cancer-related Molecular Pathways
  • CAR-T cell therapy research
  • Drug Solubulity and Delivery Systems
  • Protein Degradation and Inhibitors
  • Cancer Research and Treatments
  • Virus-based gene therapy research
  • Synthesis and Catalytic Reactions
  • Chemical synthesis and alkaloids
  • Natural product bioactivities and synthesis

Nankai University
2024

National Vaccine and Serum Institute
2024

Second Affiliated Hospital of Nanjing Medical University
2024

Anhui Medical University
2023-2024

China National Biotechnology (China)
2024

Shanghai Institute of Materia Medica
2018-2024

Chinese Academy of Sciences
2018-2024

State Key Laboratory of Medicinal Chemical Biology
2024

Anhui Science and Technology University
2021

Anhui University of Science and Technology
2021

PD-1/PD-L1 antibodies have achieved great success in clinical treatment. However, monoclonal antibody drugs also challenges, such as high manufacturing costs, poor diffusion, low oral bioavailability and limited penetration into tumour tissue. The development of small-molecule inhibitors interaction represents a promising perspective to overcome the above challenges cancer immunotherapy.We explored structural activity relationships used biochemical assays generate lead compound (ZE132). CD8+...

10.1111/bph.15457 article EN British Journal of Pharmacology 2021-03-26

Ketoconazole is a broad spectrum imidazole antifungal drug. For the treatment of superficial fungal infections with ketoconazole, it needs to be permeated deep skin layers. In order develop topical formulation ketoconazole for improving its deposition and water-solubility, ketoconazole-loaded methoxy poly (ethylene glycol)-b-poly (δ-valerolactone) micelles were developed through thin-film hydration method. Particle size, drug loading capacity, infrared X-ray diffraction drug-loaded...

10.1080/09205063.2016.1244371 article EN Journal of Biomaterials Science Polymer Edition 2016-10-03

Ultralow loading palladium nanoparticles were facilely synthesized on a three-dimensional graphite-coated nickel foam support by metal atomic layer deposition technology and used as promising catalyst for ethanol electro-oxidation reaction.

10.1039/c5ra24546j article EN RSC Advances 2016-01-01

Novel WN FNs/N–C consisting of nanosheets with flower-like morphology and N–C composites was prepared an improved ORR performance.

10.1039/c7ra05634f article EN cc-by-nc RSC Advances 2017-01-01

Honokiol-loaded micelles were prepared by emulsion-solvent evaporation procedure when oligochitosan-pluronic conjugate (CS-F127) as carrier. Differential scanning calorimetry (DSC) indicated that honokiol existed in amorphous form it was encapsulated into the with 87.54 ± 1.52% of encapsulation efficiency (EE) and 12.51 0.22% drug loading (DL) capacity. The water-solubility increased to 1.46 mg/mL, being >27-folds higher than pure honokiol. vitro release study demonstrated a slow sustained...

10.1080/21691401.2018.1434785 article EN Artificial Cells Nanomedicine and Biotechnology 2018-02-05
Coming Soon ...